The preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer
- 1 May 2014
- journal article
- Published by Springer Science and Business Media LLC in Surgery Today
- Vol. 45 (1), 63-67
- https://doi.org/10.1007/s00595-014-0894-4
Abstract
The plasma D-dimer (D-dimer) level, a marker of hypercoagulation, has been reported to be associated with survival in several types of cancers. This retrospective study was conducted to evaluate the prognostic significance of the preoperative D-dimer level in patients with completely resected non-small cell lung cancer (NSCLC). A total of 237 completely resected NSCLC patients were included in this study. In addition to age, sex, the smoking status, etc., the association between the preoperative D-dimer level and survival was explored. The patients were divided into three groups according to the D-dimer level: group A (≤0.50 μg/ml, n = 76), group B (0.51–0.86 μg/ml, n = 79) and group C (>0.86 μg/ml, n = 82). The 5-year overall survival rate was 89.6 % (95 % confidence interval (CI) 77.7–95.3) for group A, 75.1 % (95 % CI 62.3–83.6) for group B and 60.1 % (95 % CI 46.8–71.1) for group C (P trend <0.001). A multivariate survival analysis showed that the D-dimer level (group B vs. group A HR 4.25, group C vs. group A HR 4.11) was an independent significant prognostic factor, in addition to age, sex, the pathological stage and the serum carcinoembryonic antigen level. The preoperative D-dimer level is an independent prognostic factor in patients with completely resected NSCLC.Keywords
This publication has 18 references indexed in Scilit:
- Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolismEuropean Journal of Surgical Oncology, 2013
- High D-dimer levels are associated with poor prognosis in cancer patientsPublished by Ferrata Storti Foundation (Haematologica) ,2012
- D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcomaBMC Musculoskeletal Disorders, 2011
- Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over DecadeJournal of Thoracic Oncology, 2011
- Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung CancersJournal of Thoracic Oncology, 2011
- D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancerAnnals of Oncology, 2010
- Circulating Tumor Cell as a Diagnostic Marker in Primary Lung CancerClinical Cancer Research, 2009
- Biomarkers and Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Trousseau's syndrome: multiple definitions and multiple mechanismsBlood, 2007
- Prognostic significance of plasma D-dimer levels in patients with lung cancerThorax, 1997